This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
One of the most prominent trends shaping this industry is the outsourcing of various stages of drugdevelopment. As companies […] The article Outsourcing In DrugDevelopment: A Key Strategy for Sustainable Growth appeared first on electronichealthreporter.com.
Valo Health’s Opal Computational Platform uses machine learning, cloud computing and real-world data to assist in the drug discovery and development process.
An important part of advancing medical research and drugdevelopment is making participation in clinical trials easier and more inclusive. To develop treatments that work on men, women, and children of all ages and different ethnicities we need to have clinical trial data that represents our diverse population.
Drugdevelopment platform Quris raised another $9 million, and PharmStars is accepting applications for its accelerator cohort focused on women's health and health equity.
Among the key findings: AI's use in healthcare may reduce administrative burdens and hasten drugdevelopment and clinical diagnosis. When used properly, uses of AI could lead to increased efficiency, better patient care and better outcomes.
Daewoong Pharmaceutical , a prominent player in the South Korean pharmaceutical industry, has unveiled its groundbreaking drugdevelopment system, Daewoong AI System (DAISY). About DAISY DAISY represents the culmination of over 40 years of research and development by Daewoong Pharmaceutical.
Consumer genetic testing company 23andMe sees an opportunity to get in on the weight loss boom. 23andMe plans to launch a GLP-1 weight loss telehealth membership through its Lemonaid Health platform by the end of the month.
Also: Entos works to improve drugdevelopment after closing its Series A round and Castor plans to build out its decentralized clinical trial platform with a $45 million investment.
Drug population and drug protocol fit account for nearly 75% of these failures. By simulating trials at scale, QuantHealth’s platform can lower risks, expedite, and optimize drugdevelopment. Petra Jantzer, Ph.D.,
The field of drugdevelopment is no exception. In this blog post, we'll explore the history of AI, clarify key concepts and common questions, and delve into its use in drugdevelopment.
BGN Technologies, the technology transfer company of Ben-Gurion University (BGU), today unveiled an artificial intelligence (AI) platform for monitoring and predicting the progression of neurodegenerative diseases for the purpose of identifying markers for personalised patient care and improved drugdevelopment.
As we look forward to an exhilarating 2024, we believe this partnership will pave the way for significant advancements in the field of drug R&D for the benefit of the patients,” explained Khai Pham, CEO of ThinkingNodeLife.ai Debiopharm’s main activities include drugdevelopment, drug manufacturing and digital health investment.
Under the program, Deliberate AI’s assessment tool for anxiety and depression, the AI-generated Clinical Outcome Assessment or AI-COA , will receive support to become a qualified drugdevelopment tool (DDT). Global experts have also expressed support for Deliberate AI’s innovative approach.
Oncology is one of the most active and fastest growing areas of drugdevelopment research, outpacing other therapeutic areas in terms of study volume, complexity, cost, and duration.
Oncology is one of the most active and fastest growing areas of drugdevelopment research, outpacing other therapeutic areas in terms of study volume, complexity, cost, and duration.
BenevolentAI, a UK company using artificial intelligence for drugdevelopment, has raised $115 million in new funding, mostly from undisclosed investors in the United States. Existing backer Woodford Investment Management also participated in the round, which brings the company’s total funds raised to over $200 million.
Among these transformative innovations, artificial intelligence (AI ) stands out as a major force, reshaping the fields of drug discovery , drugdevelopment, clinical trials and patient care. The clinical trials phase represents a crucial turning point in drugdevelopment, but is often characterised by inefficiencies and delays.
On the pharma front, expect an emphasis on AI for inventory management and targeted drugdevelopment , plus a shake-up in the market for weight-loss drugs. Read more… 2025 Health IT Predictions: Pharma. We have plenty more predictions from the Healthcare IT Today community.
Artificial intelligence (AI) holds great promise to dramatically improve clinical outcomes for patients, but in a perverse twist, AI algorithms that are used to improve drugdevelopment and support healthcare don’t just highlight social inequities — they may ultimately exacerbate them. A lingering […].
The companies are evolving in many ways, including stepping outside drugdevelopment to tryout digital treatments and using lessons from the COVID-19 pandemic to rethink production and clinical trials. Where are pharma companies investing their windfall profits?
In our interview, Gil emphasizes the critical role of AI in expediting the discovery of new drugs, citing the lengthy and costly nature of traditional drugdevelopment processes. However, with AI-driven approaches, Aion Labs is paving the way for a paradigm shift in drug discovery.
Curebase today announced $15M in Series A funding to continue developing its decentralized clinical trial software platform and virtual research site capabilities, powering research where any patient, anywhere, can be part of clinical trials at home and with their own doctor.
The FDA has announced several guidelines and plans to hold at least one public meeting on digital health technologies (DHTs) to be used in drug clinical trials by the end of the year. Drugdevelopment process questions the reliability and accuracy of DHT products.
Most people don’t realize that it can take up to 15 years and an average of $1 billion to $2 billion dollars just to get one drugdeveloped, pass clinical trials and ultimately approved by […]. The article How Technology Is Improving Success Rates In Drug Clinical Trials appeared first on electronichealthreporter.com.
With ResponderID, we sought to disrupt the historical linear progression of drug discovery and development, rather aiming to close the loop between drugdevelopment, patient care and new drug discovery,” said Rafael Rosengarten, Ph.D., co-founder and CEO of Genialis. “We
This expansion mirrors a trend identified in an industry report jointly published by Biofourmis and HealthXL last year, predicting widespread adoption of digital endpoints by pharmaceutical companies in drugdevelopment programs by 2030.
23andMe tried to monetize its extensive genetic database by collaborating with pharmaceutical companies for drug research. While promising, drugdevelopment requires significant time and investment, delaying any financial returns and impacting the company’s short-term revenue.
In related news, Medable announced new data from the Tufts Center for the Study of DrugDevelopment (CSDD)s PACT Consortium that links decentralized clinical trial approaches to higher participation rates across multiple demographic groups.
In the past couple of months, Amazon announced many health-related plans and developments, including: Accepting medical and health savings accounts (HSAs) to pay for consumer health products like over-the-counter drugs.
The Digital Endpoint Collaboration to accelerate Outcome DEvelopment (DECODE) Nocturnal Scratch working group was launched in November 2023, with the goal of bringing to the market a fit-for-purpose digital measure of nocturnal scratch.
The companies drew particular attention to Labcorp DrugDevelopment, which Ascension says it can use to present physicians and patients with access to clinical trials, innovative therapies and new treatment options where appropriate. Labcorp also said it would use proprietary analytic tools and processes to improve overall efficiency.
We organize all of the trending information in your field so you don't have to. Join 48,000+ users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Drug Development Related Topics 
91 
Let's personalize your content